UroGen Pharma Ltd. (URGN) Net income 2016–2025
UroGen Pharma Ltd. (URGN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$153.5MFY2025 · since FY2016: -$1.9M → -$153.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$153.5M | -21.0% |
| FY2024 | -$126.9M | -24.1% |
| FY2023 | -$102.2M | +6.9% |
| FY2022 | -$109.8M | +0.9% |
| FY2021 | -$110.8M | +13.7% |
| FY2020 | -$128.5M | -22.2% |
| FY2019 | -$105.1M | -39.0% |
| FY2018 | -$75.7M | -278.3% |
| FY2017 | -$20.0M | -930.4% |
| FY2016 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice